Colgate-Palmolive (CL) Financials

$87.53 +0.17 (+0.19%)

Closing price 05/8/2026 03:59 PM Eastern

Extended Trading

$88.17 +0.65 (+0.74%)

As of 05/8/2026 07:41 PM Eastern

Annual Income Statements for Colgate-Palmolive

This table shows Colgate-Palmolive's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	1,384	2,441	2,024	2,400	2,367	2,695	2,166	1,785	2,300	2,889	2,132
Consolidated Net Income / (Loss)	1,548	2,586	2,174	2,558	2,527	2,860	2,338	1,967	2,455	3,049	2,261
Net Income / (Loss) Continuing Operations	1,548	2,586	2,174	2,558	2,527	2,860	2,338	1,967	2,455	3,049	2,261
Total Pre-Tax Income	2,763	3,738	3,487	3,464	3,301	3,647	3,087	2,660	3,392	3,956	3,059
Total Operating Income	2,789	3,955	3,707	3,694	3,554	3,885	3,332	2,893	3,984	4,268	3,306
Total Gross Profit	9,399	9,123	9,280	9,231	9,325	10,017	10,375	10,248	11,326	12,161	12,251
Total Revenue	16,034	15,195	15,454	15,544	15,693	16,471	17,421	17,967	19,457	20,101	20,382
Operating Revenue	16,034	15,195	15,454	15,544	15,693	16,471	17,421	17,967	19,457	20,101	20,382
Total Cost of Revenue	6,635	6,072	6,174	6,313	6,368	6,454	7,046	7,719	8,131	7,940	8,131
Operating Cost of Revenue	6,635	6,072	6,174	6,313	6,368	6,454	7,046	7,719	8,131	7,940	8,131
Total Operating Expenses	6,610	5,168	5,573	5,537	5,771	6,132	7,043	7,355	7,342	7,893	8,945
Selling, General & Admin Expense	5,464	5,143	5,400	5,389	5,575	6,019	6,407	6,565	7,151	7,729	7,903
Other Operating Expenses / (Income)	1,146	25	173	148	196	113	65	69	191	164	123
Impairment Charge	-	-	-	-	0.00	0.00	571	721	0.00	0.00	919
Total Other Income / (Expense), net	-26	-217	-220	-230	-253	-238	-245	-233	-592	-312	-247
Interest Expense	26	99	220	143	145	164	175	167	287	292	267
Interest & Investment Income	-	-	-	-	-	-	-	14	55	67	75
Other Income / (Expense), net	-	-118	-	-87	-108	-74	-70	-80	-360	-87	-55
Income Tax Expense	1,215	1,152	1,313	906	774	787	749	693	937	907	798
Net Income / (Loss) Attributable to Noncontrolling Interest	164	145	150	158	160	165	172	182	155	160	129
Basic Earnings per Share	$1.53	$2.74	$2.30	$2.76	$2.76	$3.15	$2.56	$2.13	$2.78	$3.53	$2.64
Weighted Average Basic Shares Outstanding	902.20M	891.80M	881.80M	870.60M	855.03M	848.56M	840.49M	830.38M	823.15M	811.54M	801.55M
Diluted Earnings per Share	$1.52	$2.72	$2.28	$2.75	$2.75	$3.14	$2.55	$2.13	$2.77	$3.51	$2.63
Weighted Average Diluted Shares Outstanding	902.20M	891.80M	881.80M	870.60M	855.03M	848.56M	840.49M	830.38M	823.15M	811.54M	801.55M
Weighted Average Basic & Diluted Shares Outstanding	902.20M	891.80M	881.80M	870.60M	855.03M	848.56M	840.49M	830.38M	823.15M	811.54M	801.55M
Cash Dividends to Common per Share	-	-	$1.59	$1.66	$1.71	$1.75	$1.79	$1.86	$1.91	$2.48	$2.08

This table shows Colgate-Palmolive's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	708	718	683	731	737	738	690	743	735	-36	646
Consolidated Net Income / (Loss)	747	760	729	767	776	777	726	773	766	-4.00	681
Net Income / (Loss) Continuing Operations	747	760	729	767	776	777	726	773	766	-4.00	681
Total Pre-Tax Income	956	988	967	1,010	986	993	953	1,007	992	107	892
Total Operating Income	1,029	1,072	1,047	1,092	1,065	1,064	1,076	1,080	1,059	91	964
Total Gross Profit	2,877	2,950	3,039	3,066	3,074	2,982	2,987	3,069	3,049	3,146	3,226
Total Revenue	4,915	4,950	5,065	5,058	5,033	4,945	4,911	5,110	5,131	5,230	5,324
Operating Revenue	4,915	4,950	5,065	5,058	5,033	4,945	4,911	5,110	5,131	5,230	5,324
Total Cost of Revenue	2,038	2,000	2,026	1,992	1,959	1,963	1,924	2,041	2,082	2,084	2,098
Operating Cost of Revenue	2,038	2,000	2,026	1,992	1,959	1,963	1,924	2,041	2,082	2,084	2,098
Total Operating Expenses	1,848	1,878	1,992	1,974	2,009	1,918	1,911	1,989	1,990	3,055	2,262
Selling, General & Admin Expense	1,822	1,803	1,916	1,939	1,979	1,895	1,898	1,963	1,971	2,071	2,076
Other Operating Expenses / (Income)	26	75	76	35	30	23	13	26	19	65	186
Total Other Income / (Expense), net	-73	-84	-80	-82	-79	-71	-123	-73	-67	16	-72
Interest Expense	-	-	73	78	74	189	66	71	67	63	62
Interest & Investment Income	-58	-	15	18	18	-	15	21	21	18	16
Other Income / (Expense), net	-15	-	-22	-22	-23	-	-72	-23	-21	61	-26
Income Tax Expense	209	228	238	243	210	216	227	234	226	111	211
Net Income / (Loss) Attributable to Noncontrolling Interest	39	42	46	36	39	39	36	30	31	32	35
Basic Earnings per Share	$0.86	$0.86	$0.83	$0.89	$0.90	$0.91	$0.85	$0.92	$0.91	($0.04)	$0.81
Weighted Average Basic Shares Outstanding	823.37M	823.15M	820.44M	817.09M	817.01M	811.54M	810.42M	808.22M	806.06M	801.55M	800.19M
Diluted Earnings per Share	$0.86	$0.86	$0.83	$0.89	$0.90	$0.89	$0.85	$0.91	$0.91	($0.04)	$0.80
Weighted Average Diluted Shares Outstanding	823.37M	823.15M	820.44M	817.09M	817.01M	811.54M	810.42M	808.22M	806.06M	801.55M	800.19M
Weighted Average Basic & Diluted Shares Outstanding	823.37M	823.15M	820.44M	817.09M	817.01M	811.54M	810.42M	808.22M	806.06M	801.55M	800.19M
Cash Dividends to Common per Share	$0.48	-	$0.98	$0.50	-	-	$0.52	$0.52	-	-	$0.53

This table details how cash moves in and out of Colgate-Palmolive's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-119	345	133	-793	157	5.00	-56	-57	191	130	192
Net Cash From Operating Activities	2,949	3,141	3,054	3,056	3,133	3,719	3,325	2,556	3,745	4,107	4,198
Net Cash From Continuing Operating Activities	2,949	3,141	3,054	3,056	3,133	3,719	3,325	2,556	3,745	4,107	4,198
Net Income / (Loss) Continuing Operations	1,548	2,586	2,174	2,558	2,527	2,860	2,338	1,967	2,455	3,049	2,261
Consolidated Net Income / (Loss)	1,548	2,586	2,174	2,558	2,527	2,860	2,338	1,967	2,455	3,049	2,261
Depreciation Expense	449	443	475	511	519	539	556	545	567	605	630
Non-Cash Adjustments To Reconcile Net Income	1,125	-36	137	115	5.00	59	760	848	366	186	1,132
Changes in Operating Assets and Liabilities, net	-173	148	268	-128	82	261	-329	-804	357	267	175
Net Cash From Investing Activities	-685	-499	-471	-1,170	-2,099	-779	-592	-1,601	-742	-534	-817
Net Cash From Continuing Investing Activities	-685	-499	-471	-1,170	-2,099	-779	-592	-1,601	-742	-534	-817
Purchase of Property, Plant & Equipment	-691	-593	-553	-436	-335	-410	-567	-696	-705	-561	-564
Acquisitions	-13	-5.00	0.00	-728	-1,711	-353	0.00	-809	0.00	0.00	-293
Purchase of Investments	-742	-336	-347	-169	-184	-143	-141	-470	-506	-574	-698
Sale and/or Maturity of Investments	599	378	391	156	131	124	141	322	502	564	752
Other Investing Activities, net	-68	-3.00	-6.00	7.00	0.00	3.00	-25	5.00	-33	37	-14
Net Cash From Financing Activities	-2,276	-2,233	-2,450	-2,679	-870	-2,919	-2,774	-952	-2,793	-3,389	-3,256
Net Cash From Continuing Financing Activities	-2,276	-2,233	-2,450	-2,679	-870	-2,919	-2,774	-952	-2,793	-3,389	-3,256
Repayment of Debt	-9,181	-7,274	-4,808	-725	-1,426	-564	-898	116	-1,791	-501	-1,512
Repurchase of Common Equity	-1,551	-1,335	-1,399	-1,238	-1,202	-1,476	-1,320	-1,308	-1,128	-1,739	-1,210
Payment of Dividends	-1,493	-1,508	-1,529	-1,591	-1,614	-1,753	-1,679	-1,691	-1,749	-1,789	-1,823
Issuance of Debt	9,602	7,438	4,779	546	2,874	0.00	699	1,513	1,495	2.00	1,188
Other Financing Activities, net	347	446	507	329	498	874	424	418	380	638	101
Effect of Exchange Rate Changes	-107	-64	-	-	-7.00	-16	-15	-60	-19	-54	67
Cash Interest Paid	131	162	150	194	185	188	194	151	280	302	270
Cash Income Taxes Paid	1,259	932	1,037	847	803	845	890	945	937	933	913

This table details how cash moves in and out of Colgate-Palmolive's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	132	15	113	31	124	-138	16	103	64	9.00	47
Net Cash From Operating Activities	1,152	1,136	681	990	1,167	1,269	600	884	1,261	1,453	747
Net Cash From Continuing Operating Activities	1,152	1,136	681	990	1,167	1,269	600	884	1,261	1,453	747
Net Income / (Loss) Continuing Operations	747	760	729	766	775	779	726	773	767	-5.00	681
Consolidated Net Income / (Loss)	747	760	729	766	775	779	726	773	767	-5.00	681
Depreciation Expense	144	150	150	157	150	148	148	151	158	173	156
Non-Cash Adjustments To Reconcile Net Income	51	19	49	42	71	24	81	26	70	955	205
Changes in Operating Assets and Liabilities, net	210	207	-247	25	171	318	-355	-66	266	330	-295
Net Cash From Investing Activities	-161	-143	-193	-111	-150	-80	-159	-401	-154	-103	-122
Net Cash From Continuing Investing Activities	-161	-143	-193	-111	-150	-80	-159	-401	-154	-103	-122
Purchase of Property, Plant & Equipment	-161	-197	-126	-117	-134	-184	-124	-108	-155	-177	-138
Purchase of Investments	-99	-182	-139	-104	-115	-216	-134	-250	-153	-161	-70
Sale and/or Maturity of Investments	118	238	78	100	82	304	97	253	158	244	94
Other Investing Activities, net	-19	-2.00	-6.00	10	17	16	2.00	-3.00	-297	284	-8.00
Net Cash From Financing Activities	-846	-992	-361	-845	-904	-1,279	-458	-409	-1,028	-1,361	-563
Net Cash From Continuing Financing Activities	-846	-992	-361	-845	-904	-1,279	-458	-409	-1,028	-1,361	-563
Repayment of Debt	-184	-294	205	-12	-357	-246	192	-225	-338	-1,141	33
Repurchase of Common Equity	-332	-245	-509	-480	-295	-455	-284	-232	-288	-406	-306
Payment of Dividends	-396	-506	-394	-473	-408	-514	-406	-474	-420	-523	-417
Other Financing Activities, net	66	55	336	119	156	27	40	25	18	18	127
Effect of Exchange Rate Changes	-13	14	-14	-3.00	11	-48	33	29	-15	20	-15
Cash Interest Paid	114	37	123	38	106	35	109	28	98	35	96
Cash Income Taxes Paid	276	211	150	355	257	171	139	391	182	201	176

This table presents Colgate-Palmolive's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	11,935	12,123	12,676	12,161	15,034	15,920	15,040	15,731	16,393	16,046	16,330
Total Current Assets	4,384	4,338	4,639	3,793	4,179	4,338	4,397	5,113	5,279	5,317	5,709
Cash & Equivalents	970	1,315	1,535	726	883	888	832	775	966	1,096	1,288
Accounts Receivable	1,427	1,411	1,480	1,400	1,440	1,264	1,297	1,504	1,586	1,521	1,675
Inventories, net	1,180	1,171	1,221	1,250	1,400	1,673	1,692	2,074	1,934	1,987	2,032
Other Current Assets	807	441	403	417	456	513	576	760	793	713	714
Plant, Property, & Equipment, net	3,796	3,840	4,072	3,881	3,750	3,716	3,730	4,307	4,582	4,422	4,660
Plant, Property & Equipment, gross	-	-	-	-	-	-	-	-	-	-	10,856
Accumulated Depreciation	-	-	-	-	-	-	-	-	-	-	6,196
Total Noncurrent Assets	3,755	3,945	3,965	4,487	7,105	7,866	6,913	6,311	6,532	6,307	5,961
Goodwill	2,103	2,107	2,218	2,530	3,508	3,824	3,284	3,352	3,410	3,272	3,122
Intangible Assets	1,346	1,313	1,341	1,637	2,667	2,894	2,462	1,920	1,887	1,756	1,536
Noncurrent Deferred & Refundable Income Taxes	67	301	188	152	177	291	193	135	214	195	205
Other Noncurrent Operating Assets	239	224	218	168	753	857	974	904	1,021	1,084	1,098
Total Liabilities & Shareholders' Equity	11,935	12,123	12,676	12,161	15,034	15,920	15,040	15,731	16,393	16,046	16,330
Total Liabilities	11,979	12,106	12,433	11,964	14,476	14,819	14,069	14,925	15,436	15,502	15,965
Total Current Liabilities	3,534	3,305	3,408	3,341	4,038	4,404	4,051	4,004	4,741	5,759	6,853
Short-Term Debt	302	13	11	12	514	267	51	25	330	660	1,117
Accounts Payable	1,110	1,124	1,212	1,222	1,237	1,393	1,479	1,551	1,698	1,805	2,089
Accrued Expenses	1,845	1,727	1,831	1,696	1,917	2,341	2,085	2,111	2,377	2,891	3,264
Current Deferred & Payable Income Tax Liabilities	277	441	354	411	370	403	436	317	336	403	383
Total Noncurrent Liabilities	8,445	8,801	9,025	8,623	10,438	10,415	10,018	10,921	10,695	9,743	9,112
Long-Term Debt	6,246	6,520	6,566	6,354	7,333	7,334	7,194	8,741	8,219	7,289	6,871
Noncurrent Deferred & Payable Income Tax Liabilities	233	246	204	235	507	426	395	383	361	343	181
Other Noncurrent Operating Liabilities	1,966	2,035	2,255	2,034	2,598	2,655	2,429	1,797	2,115	2,111	2,060
Total Equity & Noncontrolling Interests	-44	17	243	197	558	1,101	971	806	957	544	365
Total Preferred & Common Equity	-299	-243	-60	-102	117	743	609	401	609	212	54
Total Common Equity	-299	-243	-60	-102	117	743	609	401	609	212	54
Common Stock	2,904	3,157	3,450	3,670	3,954	4,435	4,735	5,012	5,274	5,647	5,788
Retained Earnings	18,861	19,922	20,531	21,615	22,501	23,699	24,350	24,573	25,289	26,145	26,595
Treasury Stock	-18,102	-19,135	-20,181	-21,196	-22,063	-23,045	-24,089	-25,128	-26,017	-27,358	-28,450
Accumulated Other Comprehensive Income / (Loss)	-3,950	-4,180	-3,855	-4,188	-4,273	-4,345	-4,386	-4,055	-3,937	-4,222	-3,879
Noncontrolling Interest	255	260	303	299	441	358	362	405	348	332	311

This table presents Colgate-Palmolive's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	16,227	16,043	16,393	16,571	16,480	16,774	16,046	16,647	17,470	17,513	16,610
Total Current Assets	5,437	5,357	5,279	5,640	5,646	5,806	5,317	5,814	5,996	6,039	6,082
Cash & Equivalents	819	951	966	1,079	1,110	1,234	1,096	1,112	1,215	1,279	1,335
Accounts Receivable	1,656	1,577	1,586	1,813	1,825	1,712	1,521	1,725	1,773	1,807	1,889
Inventories, net	2,039	1,931	1,934	1,914	1,922	2,041	1,987	2,125	2,120	2,109	2,086
Other Current Assets	923	898	793	834	789	819	713	852	888	844	772
Plant, Property, & Equipment, net	4,431	4,409	4,582	4,497	4,392	4,421	4,422	4,416	4,529	4,560	4,622
Plant, Property & Equipment, gross	9,988	9,979	-	10,261	10,167	10,238	-	10,276	10,665	10,847	10,887
Accumulated Depreciation	5,557	5,570	-	5,764	5,775	5,817	-	5,860	6,136	6,287	6,265
Total Noncurrent Assets	6,359	6,277	6,532	6,434	6,442	6,547	6,307	6,417	6,945	6,914	5,906
Goodwill	3,373	3,327	3,410	3,341	3,320	3,389	3,272	3,334	3,696	3,702	3,107
Intangible Assets	1,901	1,861	1,887	1,837	1,814	1,834	1,756	1,782	1,904	1,889	1,521
Noncurrent Deferred & Refundable Income Taxes	186	202	214	222	214	219	195	211	218	216	211
Other Noncurrent Operating Assets	899	887	1,021	1,034	1,094	1,105	1,084	1,090	1,127	1,107	1,067
Total Liabilities & Shareholders' Equity	16,227	16,043	16,393	16,571	16,480	16,774	16,046	16,647	17,470	17,513	16,610
Total Liabilities	15,912	15,637	15,436	15,954	15,998	15,938	15,502	15,914	16,418	16,275	16,124
Total Current Liabilities	4,632	4,602	4,741	5,314	5,350	5,565	5,759	6,861	6,775	6,496	5,934
Short-Term Debt	35	34	330	538	530	527	660	1,698	1,614	1,113	36
Accounts Payable	1,544	1,482	1,698	1,646	1,557	1,625	1,805	1,800	1,790	1,866	2,096
Accrued Expenses	2,600	2,732	2,377	2,720	2,864	3,066	2,891	2,873	3,050	3,178	3,358
Current Deferred & Payable Income Tax Liabilities	453	354	336	410	399	347	403	490	321	339	444
Total Noncurrent Liabilities	11,280	11,035	10,695	10,640	10,648	10,373	9,743	9,053	9,643	9,779	10,190
Long-Term Debt	8,954	8,690	8,219	8,151	8,146	7,909	7,289	6,571	7,144	7,306	7,937
Noncurrent Deferred & Payable Income Tax Liabilities	363	430	361	392	355	320	343	302	279	304	198
Other Noncurrent Operating Liabilities	1,963	1,915	2,115	2,097	2,147	2,144	2,111	2,180	2,220	2,169	2,055
Total Equity & Noncontrolling Interests	315	406	957	617	482	836	544	733	1,052	1,238	486
Total Preferred & Common Equity	-64	-9.00	609	230	123	435	212	363	702	856	145
Total Common Equity	-64	-9.00	609	230	123	435	212	363	702	856	145
Common Stock	5,154	5,228	5,274	5,428	5,501	5,608	5,647	5,668	5,712	5,750	5,856
Retained Earnings	24,258	24,571	25,289	25,164	25,486	25,814	26,145	26,413	26,735	27,051	26,816
Treasury Stock	-25,541	-25,834	-26,017	-26,343	-26,736	-26,913	-27,358	-27,602	-27,821	-28,057	-28,656
Accumulated Other Comprehensive Income / (Loss)	-3,935	-3,974	-3,937	-4,019	-4,128	-4,074	-4,222	-4,116	-3,924	-3,888	-3,871
Noncontrolling Interest	379	415	348	387	359	401	332	370	350	382	341

This table displays calculated financial ratios and metrics derived from Colgate-Palmolive's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-7.19%	-5.23%	1.70%	0.58%	0.96%	4.96%	5.77%	3.13%	8.29%	3.31%	1.40%
EBITDA Growth	-19.03%	32.18%	-2.29%	-1.53%	-3.72%	9.71%	-12.23%	-12.05%	24.81%	14.20%	-18.91%
EBIT Growth	-21.59%	37.58%	-3.39%	-2.70%	-4.46%	10.59%	-14.41%	-13.76%	28.83%	15.37%	-22.24%
NOPAT Growth	-33.65%	75.10%	-15.53%	18.03%	-0.26%	11.98%	-17.17%	-15.23%	34.79%	14.08%	-25.72%
Net Income Growth	-33.82%	67.05%	-15.93%	17.66%	-1.21%	13.18%	-18.25%	-15.87%	24.81%	24.20%	-25.84%
EPS Growth	-35.59%	78.95%	-16.18%	20.61%	0.00%	14.18%	-18.79%	-16.47%	30.05%	26.71%	-25.07%
Operating Cash Flow Growth	-10.58%	6.51%	-2.77%	0.07%	2.52%	18.70%	-10.59%	-23.13%	46.52%	9.67%	2.22%
Free Cash Flow Firm Growth	-21.30%	22.75%	-25.50%	-3.77%	-52.40%	165.97%	7.22%	-75.41%	332.39%	41.14%	-37.38%
Invested Capital Growth	-14.12%	-5.40%	0.96%	10.44%	28.87%	3.88%	-5.50%	19.14%	-2.92%	-13.38%	-4.49%
Revenue Q/Q Growth	-1.97%	-1.16%	1.12%	-0.52%	1.32%	1.91%	0.46%	1.27%	1.68%	-0.02%	1.42%
EBITDA Q/Q Growth	-25.95%	34.42%	-2.47%	-3.54%	-1.52%	-0.68%	-14.95%	-4.74%	14.32%	-1.99%	-18.26%
EBIT Q/Q Growth	-28.91%	39.88%	-2.96%	-4.15%	-1.94%	-0.94%	-17.12%	-5.38%	16.38%	-2.22%	-21.53%
NOPAT Q/Q Growth	-41.05%	72.50%	-12.92%	12.76%	1.54%	0.68%	-17.50%	-5.47%	35.11%	0.25%	-25.94%
Net Income Q/Q Growth	-41.25%	68.25%	-11.23%	12.79%	1.57%	0.35%	-17.73%	-6.87%	41.25%	0.56%	-25.67%
EPS Q/Q Growth	-44.73%	76.62%	-11.97%	13.64%	1.85%	0.32%	-18.79%	-6.99%	44.27%	0.86%	-26.12%
Operating Cash Flow Q/Q Growth	-2.16%	-0.54%	-2.08%	3.49%	3.57%	-0.19%	4.49%	-14.49%	14.11%	3.35%	4.58%
Free Cash Flow Firm Q/Q Growth	-21.79%	46.76%	-16.03%	1.77%	3.84%	-10.66%	13.00%	-56.38%	35.47%	29.51%	-6.22%
Invested Capital Q/Q Growth	-6.76%	-4.00%	-2.38%	2.49%	1.97%	6.75%	-4.91%	5.19%	4.41%	-7.97%	-15.67%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	58.62%	60.04%	60.05%	59.39%	59.42%	60.82%	59.55%	57.04%	58.21%	60.50%	60.11%
EBITDA Margin	20.19%	28.17%	27.06%	26.49%	25.27%	26.41%	21.92%	18.69%	21.54%	23.81%	19.04%
Operating Margin	17.39%	26.03%	23.99%	23.76%	22.65%	23.59%	19.13%	16.10%	20.48%	21.23%	16.22%
EBIT Margin	17.39%	25.25%	23.99%	23.21%	21.96%	23.14%	18.72%	15.66%	18.63%	20.80%	15.95%
Profit (Net Income) Margin	9.65%	17.02%	14.07%	16.46%	16.10%	17.36%	13.42%	10.95%	12.62%	15.17%	11.09%
Tax Burden Percent	56.03%	69.18%	62.35%	73.85%	76.55%	78.42%	75.74%	73.95%	72.38%	77.07%	73.91%
Interest Burden Percent	99.07%	97.42%	94.07%	96.04%	95.79%	95.70%	94.64%	94.56%	93.60%	94.62%	94.09%
Effective Tax Rate	43.97%	30.82%	37.65%	26.15%	23.45%	21.58%	24.26%	26.05%	27.62%	22.93%	26.09%
Return on Invested Capital (ROIC)	26.09%	50.81%	43.94%	49.05%	40.73%	39.73%	33.21%	26.44%	33.26%	41.28%	33.79%
ROIC Less NNEP Spread (ROIC-NNEP)	25.82%	48.03%	41.26%	45.87%	37.66%	37.00%	30.38%	24.05%	27.76%	37.95%	31.10%
Return on Net Nonoperating Assets (RNNOA)	204.78%	-19,206.37%	1,628.37%	1,113.67%	628.67%	305.05%	192.47%	194.94%	245.24%	364.98%	463.68%
Return on Equity (ROE)	230.87%	-19,155.56%	1,672.31%	1,162.73%	669.40%	344.79%	225.68%	221.38%	278.50%	406.26%	497.47%
Cash Return on Invested Capital (CROIC)	41.29%	56.37%	42.99%	39.13%	15.51%	35.92%	38.87%	8.98%	36.23%	55.62%	38.38%
Operating Return on Assets (OROA)	21.97%	31.90%	29.90%	29.05%	25.34%	24.62%	21.07%	18.28%	22.56%	25.78%	20.08%
Return on Assets (ROA)	12.19%	21.50%	17.53%	20.60%	18.58%	18.48%	15.10%	12.78%	15.28%	18.80%	13.97%
Return on Common Equity (ROCE)	145.65%	-384,530.04%	-1,948.88%	-428.10%	13.30%	178.73%	147.26%	125.83%	159.55%	222.21%	145.57%
Return on Equity Simple (ROE_SIMPLE)	-517.73%	-1,064.20%	-3,623.33%	-2,507.84%	2,159.83%	384.93%	383.91%	490.52%	403.12%	1,438.21%	0.00%
Net Operating Profit after Tax (NOPAT)	1,563	2,736	2,311	2,728	2,721	3,047	2,524	2,139	2,883	3,289	2,444
NOPAT Margin	9.75%	18.01%	14.96%	17.55%	17.34%	18.50%	14.49%	11.91%	14.82%	16.36%	11.99%
Net Nonoperating Expense Percent (NNEP)	0.27%	2.78%	2.67%	3.18%	3.07%	2.73%	2.83%	2.39%	5.50%	3.33%	2.69%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	22.35%	30.33%	38.73%	29.25%
Cost of Revenue to Revenue	41.38%	39.96%	39.95%	40.61%	40.58%	39.18%	40.45%	42.96%	41.79%	39.50%	39.89%
SG&A Expenses to Revenue	34.08%	33.85%	34.94%	34.67%	35.53%	36.54%	36.78%	36.54%	36.75%	38.45%	38.77%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	41.22%	34.01%	36.06%	35.62%	36.77%	37.23%	40.43%	40.94%	37.73%	39.27%	43.89%
Earnings before Interest and Taxes (EBIT)	2,789	3,837	3,707	3,607	3,446	3,811	3,262	2,813	3,624	4,181	3,251
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	3,238	4,280	4,182	4,118	3,965	4,350	3,818	3,358	4,191	4,786	3,881
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	455.60	91.25	111.74	155.64	104.85	348.38	1,172.36
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	3.07	3.22	3.69	2.93	3.40	4.12	3.91	3.47	3.28	3.67	3.11
Price to Earnings (P/E)	35.52	20.05	28.16	18.95	22.52	25.16	31.42	34.96	27.76	25.56	29.69
Dividend Yield	2.74%	2.82%	2.45%	3.17%	2.75%	2.21%	2.22%	2.49%	2.46%	2.19%	2.62%
Earnings Yield	2.82%	4.99%	3.55%	5.28%	4.44%	3.98%	3.18%	2.86%	3.60%	3.91%	3.37%
Enterprise Value to Invested Capital (EV/IC)	9.94	10.39	11.79	8.81	8.07	9.58	10.13	8.05	8.41	10.96	9.95
Enterprise Value to Revenue (EV/Rev)	3.43	3.58	4.03	3.31	3.87	4.55	4.30	3.94	3.69	4.03	3.45
Enterprise Value to EBITDA (EV/EBITDA)	16.98	12.71	14.91	12.49	15.31	17.21	19.60	21.09	17.13	16.93	18.12
Enterprise Value to EBIT (EV/EBIT)	19.72	14.18	16.82	14.26	17.62	19.65	22.94	25.17	19.81	19.38	21.63
Enterprise Value to NOPAT (EV/NOPAT)	35.20	19.89	26.97	18.85	22.31	24.57	29.65	33.10	24.90	24.64	28.78
Enterprise Value to Operating Cash Flow (EV/OCF)	18.65	17.32	20.41	16.83	19.38	20.13	22.50	27.70	19.17	19.73	16.75
Enterprise Value to Free Cash Flow (EV/FCFF)	22.24	17.93	27.57	23.63	58.62	27.18	25.33	97.49	22.86	18.28	25.33
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	-148.82	384.29	27.07	32.31	14.06	6.90	7.46	10.88	8.93	14.61	21.88
Long-Term Debt to Equity	-141.95	383.53	27.02	32.25	13.14	6.66	7.41	10.84	8.59	13.40	18.82
Financial Leverage	7.93	-399.85	39.46	24.28	16.69	8.24	6.33	8.11	8.83	9.62	14.91
Leverage Ratio	18.94	-891.04	95.38	56.45	36.02	18.66	14.94	17.32	18.22	21.61	35.62
Compound Leverage Factor	18.76	-868.05	89.72	54.21	34.50	17.86	14.14	16.37	17.05	20.45	33.51
Debt to Total Capital	100.68%	99.74%	96.44%	97.00%	93.36%	87.35%	88.18%	91.58%	89.93%	93.59%	95.63%
Short-Term Debt to Total Capital	4.64%	0.20%	0.16%	0.18%	6.12%	3.07%	0.62%	0.26%	3.47%	7.77%	13.37%
Long-Term Debt to Total Capital	96.03%	99.54%	96.28%	96.82%	87.25%	84.28%	87.56%	91.32%	86.46%	85.82%	82.26%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	3.92%	3.97%	4.44%	4.56%	5.25%	4.11%	4.41%	4.23%	3.66%	3.91%	3.72%
Common Equity to Total Capital	-4.60%	-3.71%	-0.88%	-1.55%	1.39%	8.54%	7.41%	4.19%	6.41%	2.50%	0.65%
Debt to EBITDA	2.02	1.53	1.57	1.55	1.98	1.75	1.90	2.61	2.04	1.66	2.06
Net Debt to EBITDA	1.72	1.22	1.21	1.37	1.76	1.54	1.68	2.38	1.81	1.43	1.73
Long-Term Debt to EBITDA	1.93	1.52	1.57	1.54	1.85	1.69	1.88	2.60	1.96	1.52	1.77
Debt to NOPAT	4.19	2.39	2.85	2.33	2.88	2.49	2.87	4.10	2.96	2.42	3.27
Net Debt to NOPAT	3.57	1.91	2.18	2.07	2.56	2.20	2.54	3.74	2.63	2.08	2.74
Long-Term Debt to NOPAT	4.00	2.38	2.84	2.33	2.70	2.41	2.85	4.09	2.85	2.22	2.81
Altman Z-Score	6.87	7.13	7.32	7.07	6.12	6.65	7.07	6.51	6.60	7.22	6.48
Noncontrolling Interest Sharing Ratio	36.91%	-1,907.41%	216.54%	136.82%	98.01%	48.16%	34.75%	43.16%	42.71%	45.30%	70.74%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.24	1.31	1.36	1.14	1.03	0.99	1.09	1.28	1.11	0.92	0.83
Quick Ratio	0.68	0.82	0.88	0.64	0.58	0.49	0.53	0.57	0.54	0.45	0.43
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	2,473	3,035	2,261	2,176	1,036	2,755	2,954	726	3,140	4,432	2,776
Operating Cash Flow to CapEx	426.77%	589.31%	552.26%	700.92%	935.22%	907.07%	586.42%	393.84%	531.21%	732.09%	744.33%
Free Cash Flow to Firm to Interest Expense	95.10	30.66	10.28	15.22	7.14	16.80	16.88	4.35	10.94	15.18	10.40
Operating Cash Flow to Interest Expense	113.42	31.73	13.88	21.37	21.61	22.68	19.00	15.31	13.05	14.07	15.72
Operating Cash Flow Less CapEx to Interest Expense	86.85	26.34	11.37	18.32	19.30	20.18	15.76	11.42	10.59	12.14	13.61
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.26	1.26	1.25	1.25	1.15	1.06	1.13	1.17	1.21	1.24	1.26
Accounts Receivable Turnover	10.76	10.71	10.69	10.79	11.05	12.18	13.60	12.83	12.59	12.94	12.75
Inventory Turnover	5.18	5.17	5.16	5.11	4.81	4.20	4.19	4.10	4.06	4.05	4.05
Fixed Asset Turnover	4.07	3.98	3.91	3.91	4.11	4.41	4.68	4.47	4.38	4.46	4.49
Accounts Payable Turnover	5.67	5.44	5.29	5.19	5.18	4.91	4.91	5.10	5.01	4.53	4.18
Days Sales Outstanding (DSO)	33.91	34.09	34.14	33.81	33.03	29.96	26.83	28.45	28.98	28.21	28.62
Days Inventory Outstanding (DIO)	70.47	70.66	70.71	71.43	75.95	86.90	87.16	89.04	89.96	90.12	90.21
Days Payable Outstanding (DPO)	64.39	67.15	69.05	70.36	70.47	74.37	74.39	71.64	72.92	80.52	87.40
Cash Conversion Cycle (CCC)	39.99	37.60	35.80	34.88	38.50	42.49	39.60	45.85	46.02	37.82	31.42
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	5,534	5,235	5,285	5,837	7,522	7,814	7,384	8,797	8,540	7,397	7,065
Invested Capital Turnover	2.68	2.82	2.94	2.80	2.35	2.15	2.29	2.22	2.24	2.52	2.82
Increase / (Decrease) in Invested Capital	-910	-299	50	552	1,685	292	-430	1,413	-257	-1,143	-332
Enterprise Value (EV)	54,996	54,412	62,334	51,425	60,710	74,869	74,828	70,806	71,784	81,041	70,319
Market Capitalization	49,163	48,934	56,989	45,486	53,305	67,798	68,053	62,410	63,853	73,856	63,308
Book Value per Share	($0.33)	($0.27)	($0.07)	($0.12)	$0.14	$0.87	$0.72	$0.48	$0.74	$0.26	$0.07
Tangible Book Value per Share	($4.18)	($4.12)	($4.12)	($4.92)	($7.07)	($6.97)	($6.09)	($5.83)	($5.69)	($5.89)	($5.71)
Total Capital	6,504	6,550	6,820	6,563	8,405	8,702	8,216	9,572	9,506	8,493	8,353
Total Debt	6,548	6,533	6,577	6,366	7,847	7,601	7,245	8,766	8,549	7,949	7,988
Total Long-Term Debt	6,246	6,520	6,566	6,354	7,333	7,334	7,194	8,741	8,219	7,289	6,871
Net Debt	5,578	5,218	5,042	5,640	6,964	6,713	6,413	7,991	7,583	6,853	6,700
Capital Expenditures (CapEx)	691	533	553	436	335	410	567	649	705	561	564
Debt-free, Cash-free Net Working Capital (DFCFNWC)	182	-269	-293	-262	-228	-687	-435	359	-98	-878	-1,315
Debt-free Net Working Capital (DFNWC)	1,152	1,046	1,242	464	655	201	397	1,134	868	218	-27
Net Working Capital (NWC)	850	1,033	1,231	452	141	-66	346	1,109	538	-442	-1,144
Net Nonoperating Expense (NNE)	15	150	137	170	194	187	186	172	428	240	183
Net Nonoperating Obligations (NNO)	5,578	5,218	5,042	5,640	6,964	6,713	6,413	7,991	7,583	6,853	6,700
Total Depreciation and Amortization (D&A)	449	443	475	511	519	539	556	545	567	605	630
Debt-free, Cash-free Net Working Capital to Revenue	1.14%	-1.77%	-1.90%	-1.69%	-1.45%	-4.17%	-2.50%	2.00%	-0.50%	-4.37%	-6.45%
Debt-free Net Working Capital to Revenue	7.18%	6.88%	8.04%	2.99%	4.17%	1.22%	2.28%	6.31%	4.46%	1.08%	-0.13%
Net Working Capital to Revenue	5.30%	6.80%	7.97%	2.91%	0.90%	-0.40%	1.99%	6.17%	2.77%	-2.20%	-5.61%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.53	$2.74	$0.00	$2.76	$2.76	$3.15	$2.56	$2.13	$2.78	$3.53	$2.64
Adjusted Weighted Average Basic Shares Outstanding	892.74M	882.86M	0.00	861.68M	855.03M	848.56M	840.49M	830.38M	823.15M	811.54M	801.55M
Adjusted Diluted Earnings per Share	$1.52	$2.72	$0.00	$2.75	$2.75	$3.14	$2.55	$2.13	$2.77	$3.51	$2.63
Adjusted Weighted Average Diluted Shares Outstanding	892.74M	882.86M	0.00	861.68M	855.03M	848.56M	840.49M	830.38M	823.15M	811.54M	801.55M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	892.74M	882.86M	0.00	861.68M	855.03M	848.56M	840.49M	830.38M	823.15M	811.54M	801.55M
Normalized Net Operating Profit after Tax (NOPAT)	1,563	2,736	2,311	2,728	2,721	3,047	2,956	2,672	2,883	3,289	3,123
Normalized NOPAT Margin	9.75%	18.01%	14.96%	17.55%	17.34%	18.50%	16.97%	14.87%	14.82%	16.36%	15.32%
Pre Tax Income Margin	17.23%	24.60%	22.56%	22.29%	21.03%	22.14%	17.72%	14.80%	17.43%	19.68%	15.01%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	107.27	38.76	16.85	25.22	23.77	23.24	18.64	16.84	12.63	14.32	12.18
NOPAT to Interest Expense	60.10	27.64	10.51	19.08	18.76	18.58	14.42	12.81	10.05	11.27	9.15
EBIT Less CapEx to Interest Expense	80.69	33.37	14.34	22.17	21.46	20.74	15.40	12.96	10.17	12.40	10.06
NOPAT Less CapEx to Interest Expense	33.52	22.25	7.99	16.03	16.45	16.08	11.18	8.92	7.59	9.34	7.04
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	96.45%	58.31%	70.33%	62.20%	63.87%	61.29%	71.81%	85.97%	71.24%	58.68%	80.63%
Augmented Payout Ratio	196.64%	109.94%	134.68%	110.59%	111.44%	112.90%	128.27%	152.47%	117.19%	115.71%	134.14%

This table displays calculated financial ratios and metrics derived from Colgate-Palmolive's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	800,189,310.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	800,189,310.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	0.81
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	10.33%	6.93%	6.18%	4.89%	2.40%	-0.10%	-3.04%	1.03%	1.95%	5.76%	8.41%
EBITDA Growth	8.63%	279.50%	58.14%	11.62%	4.92%	-0.82%	-1.96%	-1.55%	0.34%	-72.73%	-5.03%
EBIT Growth	8.80%	473.26%	66.67%	12.12%	5.03%	-0.75%	-2.05%	-1.22%	-0.38%	-85.44%	-6.57%
NOPAT Growth	11.05%	1,153.16%	17.66%	41.42%	4.25%	0.96%	3.85%	-0.03%	-2.44%	-100.41%	-10.22%
Net Income Growth	9.53%	1,667.44%	76.09%	43.63%	3.88%	2.24%	-0.41%	0.78%	-1.29%	-100.51%	-6.20%
EPS Growth	16.22%	8,500.00%	84.44%	48.33%	4.65%	3.49%	2.41%	2.25%	1.11%	-104.49%	-5.88%
Operating Cash Flow Growth	18.89%	68.80%	-7.35%	37.12%	1.30%	11.71%	-11.89%	-10.71%	8.05%	14.50%	24.50%
Free Cash Flow Firm Growth	683.84%	180.29%	405.58%	695.55%	-0.90%	82.65%	12.60%	-77.73%	-51.21%	-83.37%	29.85%
Invested Capital Growth	-2.20%	-2.92%	-2.81%	-5.15%	-1.72%	-13.38%	-4.10%	6.80%	4.23%	-4.49%	-9.71%
Revenue Q/Q Growth	1.93%	0.71%	2.32%	-0.14%	-0.49%	-1.75%	-0.69%	4.05%	0.41%	1.93%	1.80%
EBITDA Q/Q Growth	3.49%	5.53%	-2.08%	6.30%	-2.72%	-0.25%	-4.95%	4.86%	-0.99%	-72.83%	236.62%
EBIT Q/Q Growth	4.11%	5.72%	-2.38%	6.54%	-2.47%	-0.09%	-5.64%	5.28%	-1.80%	-85.36%	517.11%
NOPAT Q/Q Growth	37.12%	2.56%	-4.28%	5.06%	1.07%	-0.67%	-1.54%	1.14%	-1.36%	-100.42%	21,734.24%
Net Income Q/Q Growth	39.89%	1.74%	-4.08%	5.21%	1.17%	0.13%	-6.56%	6.47%	-0.91%	-100.52%	17,125.00%
EPS Q/Q Growth	43.33%	0.00%	-3.49%	7.23%	1.12%	-1.11%	-4.49%	7.06%	0.00%	-104.40%	2,100.00%
Operating Cash Flow Q/Q Growth	59.56%	-1.39%	-40.05%	45.37%	17.88%	8.74%	-52.72%	47.33%	42.65%	15.23%	-48.59%
Free Cash Flow Firm Q/Q Growth	564.69%	9.47%	-5.02%	23.26%	-22.67%	101.76%	-41.45%	-75.62%	69.39%	-31.22%	357.08%
Invested Capital Q/Q Growth	-3.61%	4.41%	-3.67%	-2.18%	-0.12%	-7.97%	6.66%	8.94%	-2.52%	-15.67%	0.84%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	58.54%	59.60%	60.00%	60.62%	61.08%	60.30%	60.82%	60.06%	59.42%	60.15%	60.59%
EBITDA Margin	23.56%	24.69%	23.20%	24.69%	24.14%	24.51%	23.46%	23.64%	23.31%	6.21%	20.55%
Operating Margin	20.94%	21.66%	20.67%	21.59%	21.16%	21.52%	21.91%	21.14%	20.64%	1.74%	18.11%
EBIT Margin	20.63%	21.66%	20.24%	21.59%	21.16%	21.52%	20.44%	20.68%	20.23%	2.91%	17.62%
Profit (Net Income) Margin	15.20%	15.35%	14.39%	15.16%	15.42%	15.71%	14.78%	15.13%	14.93%	-0.08%	12.79%
Tax Burden Percent	78.14%	76.92%	75.39%	75.94%	78.70%	78.25%	76.18%	76.76%	77.22%	-3.74%	76.35%
Interest Burden Percent	94.28%	92.16%	94.34%	92.49%	92.58%	93.33%	94.92%	95.27%	95.57%	70.39%	95.10%
Effective Tax Rate	21.86%	23.08%	24.61%	24.06%	21.30%	21.75%	23.82%	23.24%	22.78%	103.74%	23.65%
Return on Invested Capital (ROIC)	37.85%	37.39%	36.88%	39.64%	41.29%	42.47%	41.32%	38.99%	39.02%	-0.18%	38.29%
ROIC Less NNEP Spread (ROIC-NNEP)	37.09%	36.56%	36.11%	38.85%	40.46%	41.70%	40.05%	38.25%	38.30%	-0.19%	37.50%
Return on Net Nonoperating Assets (RNNOA)	383.45%	322.98%	542.34%	767.08%	487.88%	401.06%	438.04%	376.73%	264.85%	-2.87%	424.32%
Return on Equity (ROE)	421.30%	360.38%	579.23%	806.73%	529.18%	443.53%	479.36%	415.72%	303.87%	-3.05%	462.62%
Cash Return on Invested Capital (CROIC)	28.03%	36.23%	38.87%	44.57%	42.21%	55.62%	45.38%	33.32%	36.06%	38.38%	41.65%
Operating Return on Assets (OROA)	24.42%	26.23%	24.41%	26.39%	25.93%	26.67%	24.55%	24.37%	23.72%	3.66%	22.03%
Return on Assets (ROA)	17.99%	18.60%	17.36%	18.53%	18.89%	19.47%	17.75%	17.82%	17.50%	-0.10%	16.00%
Return on Common Equity (ROCE)	177.01%	206.45%	124.52%	59.72%	181.51%	242.60%	210.56%	223.58%	189.15%	-0.89%	192.79%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.00%	1,204.35%	2,441.46%	697.01%	0.00%	839.12%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	804	825	789	829	838	833	820	829	818	-3.40	736
NOPAT Margin	16.36%	16.66%	15.58%	16.40%	16.65%	16.84%	16.69%	16.22%	15.94%	-0.07%	13.82%
Net Nonoperating Expense Percent (NNEP)	0.76%	0.83%	0.77%	0.79%	0.83%	0.77%	1.27%	0.74%	0.72%	0.01%	0.80%
Return On Investment Capital (ROIC_SIMPLE)	-	8.67%	-	-	-	9.80%	9.11%	8.45%	8.47%	-0.04%	8.70%
Cost of Revenue to Revenue	41.46%	40.40%	40.00%	39.38%	38.92%	39.70%	39.18%	39.94%	40.58%	39.85%	39.41%
SG&A Expenses to Revenue	37.07%	36.42%	37.83%	38.34%	39.32%	38.32%	38.65%	38.41%	38.41%	39.60%	38.99%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	37.60%	37.94%	39.33%	39.03%	39.92%	38.79%	38.91%	38.92%	38.78%	58.41%	42.49%
Earnings before Interest and Taxes (EBIT)	1,014	1,072	1,025	1,092	1,065	1,064	1,004	1,057	1,038	152	938
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1,158	1,222	1,175	1,249	1,215	1,212	1,152	1,208	1,196	325	1,094
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	104.85	320.51	644.00	194.02	348.38	208.31	104.31	74.98	1,172.36	468.23
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	2.99	3.28	3.73	3.96	4.20	3.67	3.79	3.66	3.19	3.11	3.26
Price to Earnings (P/E)	36.01	27.76	28.23	27.89	29.42	25.56	26.11	25.18	22.09	29.69	32.52
Dividend Yield	2.75%	2.46%	2.14%	2.01%	1.90%	2.19%	2.15%	2.24%	2.57%	2.62%	2.46%
Earnings Yield	2.78%	3.60%	3.54%	3.59%	3.40%	3.91%	3.83%	3.97%	4.53%	3.37%	3.08%
Enterprise Value to Invested Capital (EV/IC)	7.99	8.41	9.93	10.83	11.45	10.96	10.54	9.44	8.56	9.95	10.51
Enterprise Value to Revenue (EV/Rev)	3.41	3.69	4.14	4.36	4.58	4.03	4.17	4.06	3.57	3.45	3.60
Enterprise Value to EBITDA (EV/EBITDA)	17.82	17.13	17.68	18.00	18.84	16.93	17.46	17.10	15.10	18.12	19.58
Enterprise Value to EBIT (EV/EBIT)	20.98	19.81	20.26	20.55	21.52	19.38	19.99	19.56	17.31	21.63	23.51
Enterprise Value to NOPAT (EV/NOPAT)	30.61	24.90	27.18	26.83	28.04	24.64	25.04	24.43	21.73	28.78	31.71
Enterprise Value to Operating Cash Flow (EV/OCF)	19.91	19.17	22.14	22.01	23.15	19.73	20.65	20.69	17.86	16.75	17.23
Enterprise Value to Free Cash Flow (EV/FCFF)	28.18	22.86	25.19	23.65	26.88	18.28	22.73	29.25	24.23	25.33	23.95
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	21.49	8.93	14.08	18.00	10.09	14.61	11.28	8.33	6.80	21.88	16.41
Long-Term Debt to Equity	21.40	8.59	13.21	16.90	9.46	13.40	8.96	6.79	5.90	18.82	16.33
Financial Leverage	10.34	8.83	15.02	19.74	12.06	9.62	10.94	9.85	6.92	14.91	11.32
Leverage Ratio	22.16	18.22	31.42	41.04	26.42	21.61	24.61	22.13	16.53	35.62	27.28
Compound Leverage Factor	20.89	16.79	29.65	37.96	24.46	20.17	23.36	21.08	15.80	25.07	25.94
Debt to Total Capital	95.55%	89.93%	93.37%	94.74%	90.98%	93.59%	91.86%	89.28%	87.18%	95.63%	94.25%
Short-Term Debt to Total Capital	0.37%	3.47%	5.78%	5.79%	5.68%	7.77%	18.86%	16.45%	11.53%	13.37%	0.43%
Long-Term Debt to Total Capital	95.18%	86.46%	87.59%	88.95%	85.30%	85.82%	72.99%	72.82%	75.66%	82.26%	93.83%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	4.55%	3.66%	4.16%	3.92%	4.32%	3.91%	4.11%	3.57%	3.96%	3.72%	4.03%
Common Equity to Total Capital	-0.10%	6.41%	2.47%	1.34%	4.69%	2.50%	4.03%	7.16%	8.86%	0.65%	1.71%
Debt to EBITDA	2.38	2.04	1.88	1.79	1.73	1.66	1.74	1.85	1.77	2.06	2.09
Net Debt to EBITDA	2.12	1.81	1.65	1.56	1.47	1.43	1.50	1.59	1.50	1.73	1.74
Long-Term Debt to EBITDA	2.37	1.96	1.76	1.68	1.62	1.52	1.38	1.51	1.54	1.77	2.08
Debt to NOPAT	4.09	2.96	2.89	2.67	2.57	2.42	2.49	2.64	2.55	3.27	3.38
Net Debt to NOPAT	3.64	2.63	2.53	2.33	2.19	2.08	2.16	2.27	2.16	2.74	2.81
Long-Term Debt to NOPAT	4.07	2.85	2.71	2.51	2.41	2.22	1.98	2.15	2.21	2.81	3.36
Altman Z-Score	5.79	6.08	6.32	6.59	6.76	6.58	6.39	6.11	5.84	5.85	6.24
Noncontrolling Interest Sharing Ratio	57.98%	42.71%	78.50%	92.60%	65.70%	45.30%	56.07%	46.22%	37.75%	70.74%	58.33%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.16	1.11	1.06	1.06	1.04	0.92	0.85	0.89	0.93	0.83	1.02
Quick Ratio	0.55	0.54	0.54	0.55	0.53	0.45	0.41	0.44	0.48	0.43	0.54
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	988	1,082	1,027	1,266	979	1,976	1,157	282	478	329	1,502
Operating Cash Flow to CapEx	715.53%	576.65%	540.48%	846.15%	870.90%	689.67%	483.87%	818.52%	813.55%	820.90%	541.30%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	17.71	57.56	42.57	10.45	17.53	3.97	7.13	5.22	24.23
Operating Cash Flow to Interest Expense	0.00	0.00	11.74	45.00	50.74	6.71	9.09	12.45	18.82	23.06	12.05
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	9.57	39.68	44.91	5.74	7.21	10.93	16.51	20.25	9.82
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.18	1.21	1.21	1.22	1.23	1.24	1.20	1.18	1.17	1.26	1.25
Accounts Receivable Turnover	12.75	12.59	11.61	11.48	12.23	12.94	11.28	11.12	11.42	12.75	11.51
Inventory Turnover	4.09	4.06	4.03	4.07	4.02	4.05	3.88	3.90	3.86	4.05	3.94
Fixed Asset Turnover	4.49	4.38	4.46	4.53	4.55	4.46	4.48	4.48	4.48	4.49	4.60
Accounts Payable Turnover	5.42	5.01	4.98	5.20	5.13	4.53	4.55	4.71	4.59	4.18	4.26
Days Sales Outstanding (DSO)	28.63	28.98	31.44	31.78	29.85	28.21	32.37	32.83	31.96	28.62	31.72
Days Inventory Outstanding (DIO)	89.27	89.96	90.68	89.73	90.87	90.12	94.04	93.53	94.55	90.21	92.54
Days Payable Outstanding (DPO)	67.40	72.92	73.35	70.25	71.08	80.52	80.24	77.45	79.54	87.40	85.61
Cash Conversion Cycle (CCC)	50.50	46.02	48.77	51.27	49.64	37.82	46.18	48.92	46.97	31.42	38.64
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	8,179	8,540	8,227	8,048	8,038	7,397	7,890	8,595	8,378	7,065	7,124
Invested Capital Turnover	2.31	2.24	2.37	2.42	2.48	2.52	2.48	2.40	2.45	2.82	2.77
Increase / (Decrease) in Invested Capital	-184	-257	-238	-437	-141	-1,143	-337	547	340	-332	-766
Enterprise Value (EV)	65,328	71,784	81,714	87,137	92,003	81,041	83,145	81,121	71,701	70,319	74,873
Market Capitalization	57,140	63,853	73,717	79,212	84,400	73,856	75,618	73,228	64,179	63,308	67,894
Book Value per Share	($0.01)	$0.74	$0.28	$0.15	$0.53	$0.26	$0.45	$0.87	$1.06	$0.07	$0.18
Tangible Book Value per Share	($6.29)	($5.69)	($6.03)	($6.11)	($5.86)	($5.89)	($5.86)	($6.04)	($5.86)	($5.71)	($5.59)
Total Capital	9,130	9,506	9,306	9,158	9,272	8,493	9,002	9,810	9,657	8,353	8,459
Total Debt	8,724	8,549	8,689	8,676	8,436	7,949	8,269	8,758	8,419	7,988	7,973
Total Long-Term Debt	8,690	8,219	8,151	8,146	7,909	7,289	6,571	7,144	7,306	6,871	7,937
Net Debt	7,773	7,583	7,610	7,566	7,202	6,853	7,157	7,543	7,140	6,700	6,638
Capital Expenditures (CapEx)	161	197	126	117	134	184	124	108	155	177	138
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-162	-98	-215	-284	-466	-878	-461	-380	-623	-1,315	-1,151
Debt-free Net Working Capital (DFNWC)	789	868	864	826	768	218	651	835	656	-27	184
Net Working Capital (NWC)	755	538	326	296	241	-442	-1,047	-779	-457	-1,144	148
Net Nonoperating Expense (NNE)	57	65	60	62	62	56	94	56	52	0.60	55
Net Nonoperating Obligations (NNO)	7,773	7,583	7,610	7,566	7,202	6,853	7,157	7,543	7,140	6,700	6,638
Total Depreciation and Amortization (D&A)	144	150	150	157	150	148	148	151	158	173	156
Debt-free, Cash-free Net Working Capital to Revenue	-0.85%	-0.50%	-1.09%	-1.42%	-2.32%	-4.37%	-2.31%	-1.90%	-3.10%	-6.45%	-5.54%
Debt-free Net Working Capital to Revenue	4.12%	4.46%	4.37%	4.13%	3.82%	1.08%	3.26%	4.18%	3.26%	-0.13%	0.88%
Net Working Capital to Revenue	3.95%	2.77%	1.65%	1.48%	1.20%	-2.20%	-5.25%	-3.90%	-2.27%	-5.61%	0.71%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.86	$0.86	$0.83	$0.89	$0.90	$0.91	$0.85	$0.92	$0.91	($0.04)	$0.81
Adjusted Weighted Average Basic Shares Outstanding	823.37M	823.15M	820.44M	817.09M	817.01M	811.54M	810.42M	808.22M	806.06M	801.55M	800.19M
Adjusted Diluted Earnings per Share	$0.86	$0.86	$0.83	$0.89	$0.90	$0.89	$0.85	$0.91	$0.91	($0.04)	$0.80
Adjusted Weighted Average Diluted Shares Outstanding	823.37M	823.15M	820.44M	817.09M	817.01M	811.54M	810.42M	808.22M	806.06M	801.55M	800.19M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	823.37M	823.15M	820.44M	817.09M	817.01M	811.54M	810.42M	808.22M	806.06M	801.55M	800.19M
Normalized Net Operating Profit after Tax (NOPAT)	804	825	789	829	838	833	820	829	818	64	736
Normalized NOPAT Margin	16.36%	16.66%	15.58%	16.40%	16.65%	16.84%	16.69%	16.22%	15.94%	1.22%	13.82%
Pre Tax Income Margin	19.45%	19.96%	19.09%	19.97%	19.59%	20.08%	19.41%	19.71%	19.33%	2.05%	16.75%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	17.67	49.64	46.30	5.63	15.21	14.89	15.49	2.41	15.13
NOPAT to Interest Expense	0.00	0.00	13.61	37.69	36.44	4.41	12.42	11.68	12.21	-0.05	11.87
EBIT Less CapEx to Interest Expense	0.00	0.00	15.50	44.32	40.48	4.66	13.33	13.37	13.18	-0.40	12.90
NOPAT Less CapEx to Interest Expense	0.00	0.00	11.44	32.38	30.62	3.43	10.54	10.16	9.89	-2.86	9.64
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	99.42%	71.24%	63.29%	58.91%	58.74%	58.68%	59.13%	59.04%	59.63%	80.63%	82.76%
Augmented Payout Ratio	173.99%	117.19%	115.88%	111.06%	109.17%	115.71%	108.83%	100.52%	101.02%	134.14%	138.36%

Financials Breakdown Chart

Key Financial Trends

Here are concise, trend-focused takeaways from Colgate-Palmolive Co. (NYSE: CL) quarterly statements over the last four years. The items below highlight notable patterns in revenue, profitability, cash flow, and balance sheet metrics.

Gross margin stays around 60% across recent quarters (for example, Q4 2025 gross profit of $3.146B on $5.230B revenue, about 60% margin).
Cash flow from operations is strong and generally rising, with quarterly net cash from continuing operating activities around $0.9B–$1.5B; Q4 2025 CFO was $1.453B.
Earnings power is solid in most quarters, with earnings per share typically in the mid-to-high $0.80s to $0.90s (for example, Q3 2025 basic EPS $0.91, Q2 2025 $0.92, Q1 2025 $0.89).
Stable quarterly dividends of about $0.52 per share support shareholder returns.
Balance sheet liquidity remains healthy, with cash & equivalents around $1.2B–$1.3B and total assets in the mid-to-upper teens of billions, providing a solid cushion for operations and capital allocation.

Revenue has trended higher into 2025 vs. 2024, with Q4 2025 revenue of about $5.23B vs. roughly $4.95B in Q4 2024, indicating positive momentum though quarterly results can fluctuate by product mix and promotions.
Debt levels are elevated but typical for a multinational consumer staples firm, with long-term debt in the mid-to-high billions and total liabilities in the mid-teens of billions, implying ongoing leverage but stable access to financing.
Seasonality affects quarterly profitability, as Q4 can show different tax and non-operating dynamics compared with other quarters, leading to quarter-to-quarter variance in net income and cash flow.

Q4 2025 net income attributable to common shareholders was negative (-$36.0M), with basic and diluted EPS at -$0.04, signaling a quarterly dip driven by one-off tax or non-operating factors.
Net cash from financing activities in Q4 2025 was negative (~-$1.361B), reflecting ongoing dividends, share repurchases, and debt activity that reduced cash on hand despite solid operating cash flow.

05/09/26 06:46 AM ETAI Generated. May Contain Errors.

Colgate-Palmolive Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Colgate-Palmolive's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Colgate-Palmolive's net income were at $2.26 billion at the end of 2025, a 25.8% decrease from 2024, and a 46.1% increase since 2015. See Colgate-Palmolive's forecast for analyst expectations on what's next for the company.

Colgate-Palmolive's total operating income in 2025 was $3.31 billion, based on the following breakdown:

Total Gross Profit: $12.25 billion
Total Operating Expenses: $8.95 billion

Over the last 10 years, Colgate-Palmolive's total revenue changed from $16.03 billion in 2015 to $20.38 billion in 2025, a change of 27.1%.

Colgate-Palmolive's total liabilities were at $15.97 billion at the end of 2025, a 3.0% increase from 2024, and a 33.3% increase since 2015.

In the past 10 years, Colgate-Palmolive's cash and equivalents has ranged from $726 million in 2018 to $1.54 billion in 2017, and is currently $1.29 billion as of their latest financial filing in 2025.

Over the last 10 years, Colgate-Palmolive's book value per share changed from -0.33 in 2015 to 0.07 in 2025, a change of -120.1%.

Related Companies

Financial statements for NYSE:CL last updated on 5/3/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Colgate-Palmolive (CL) Financials

Financials Breakdown Chart

Key Financial Trends

Colgate-Palmolive Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Colgate-Palmolive (CL) Financials

Annual Income Statements for Colgate-Palmolive

Quarterly Income Statements for Colgate-Palmolive

Annual Cash Flow Statements for Colgate-Palmolive

Quarterly Cash Flow Statements for Colgate-Palmolive

Annual Balance Sheets for Colgate-Palmolive

Quarterly Balance Sheets for Colgate-Palmolive

Annual Metrics And Ratios for Colgate-Palmolive

Quarterly Metrics And Ratios for Colgate-Palmolive

Financials Breakdown Chart

Key Financial Trends

Colgate-Palmolive Financials - Frequently Asked Questions

When does Colgate-Palmolive's fiscal year end?

How has Colgate-Palmolive's net income changed over the last 10 years?

What is Colgate-Palmolive's operating income?

How has Colgate-Palmolive's revenue changed over the last 10 years?

How much debt does Colgate-Palmolive have?

How much cash does Colgate-Palmolive have?

How has Colgate-Palmolive's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools